APREMILAST VIATRIS 10 mg, film-coated tablet, APREMILAST VIATRIS 20 mg, film-coated tablet, APREMILAST VIATRIS 30 mg, film-coated tablet.treatment initiation pack 27 tablets
Active ingredients: Apremilast
Commercialized according to BDPMDispensing in France: Prescription only
Film-coated tablet27 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- APREMILAST VIATRIS 10 mg, comprimé pelliculé, APREMILAST VIATRIS 20 mg, comprimé pelliculé, APREMILAST VIATRIS 30 mg, comprimé pelliculé.Pack d’initiation du traitement
- Pharmaceutical form
- comprimé pelliculé et comprimé pelliculé et comprimé pelliculé
- Route of administration
- orale
- Presentation description
- plaquette(s) PVC aluminium de 27 comprimés (4 comprimés de 10 mg + 4 comprimés de 20 mg + 19 comprimés de 30 mg), Pack d’initiation
- Marketing authorisation holder
- VIATRIS SANTE
- Reimbursement according to BDPM
- 30%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 10 Jun 2026
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Prescribed by specialists only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
67253142CIP73032784CIP133400930327845Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| APRÉMILASTcomprimé 10 mg | 10 mg · un comprimé | SA |
| APRÉMILASTcomprimé 20 mg | 20 mg · un comprimé | SA |
| APRÉMILASTcomprimé 30 mg | 30 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.